2025
SJR Q1
JCR Q2 · 3,1
7 matched articles
ESCI
Journal detail
Tissue Barriers
- Publisher
- Taylor and Francis Ltd.
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
2168836221688370
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,434
- Quartile Q1
- H-Index 56
- Cites/doc 5,05
- Docs (3y) 79
- Cites (3y) 423
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3,1
- 5Y JIF 5
- JCI 0,63
WoS indexes
- ESCI
Subject classification
Categories (SJR)
- Biochemistry Q1
- Cell Biology Q2
- Histology Q1
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS categories
- Medicine, Research & Experimental
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 1,434 | 3,1 | 5 | 0,63 | Q2 | 56 |
| 2024 | Q1 | Q2 | 1,507 | 4 | 4,9 | 0,66 | Q2 | 49 |
| 2023 | Q1 | Q2 | 0,978 | 3,6 | 4,4 | 0,58 | Q3 | 49 |
| 2022 | Q2 | — | 0,89 | 3,1 | 5,6 | 0,58 | Q3 | 49 |
| 2021 | Q1 | — | 1,188 | — | — | 0,88 | Q2 | 49 |
| 2020 | Q1 | — | 1,904 | — | — | 0,94 | Q2 | 49 |
| 2019 | Q1 | — | 1,777 | — | — | — | — | 49 |
| 2017 | Q1 | — | 1,721 | — | — | — | — | 49 |
| 2016 | Q1 | — | 1,883 | — | — | — | — | 49 |
| 2015 | Q1 | — | 1,856 | — | — | — | — | 49 |
| 2014 | Q4 | — | 0,143 | — | — | — | — | 49 |
| 2013 | — | — | — | — | — | — | — | 49 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | MEDICINE, RESEARCH & EXPERIMENTAL | ESCI | Q2 | Q2 | 92/191 |
| 2024 | MEDICINE, RESEARCH & EXPERIMENTAL | ESCI | Q2 | Q2 | 62/195 |
| 2023 | MEDICINE, RESEARCH & EXPERIMENTAL | ESCI | Q2 | Q3 | 72/189 |
| 2022 | MEDICINE, RESEARCH & EXPERIMENTAL | ESCI | — | Q3 | — |
| 2021 | MEDICINE, RESEARCH & EXPERIMENTAL | ESCI | — | Q2 | — |
| 2020 | MEDICINE, RESEARCH & EXPERIMENTAL | ESCI | — | Q2 | — |